Real World Long-term Assessment of The Efficacy of Tocilizumab in Patients with COVID-19: Results From A Large De-identified Multicenter Electronic Health Record Dataset in the United States

BACKGROUND: Studies have shown conflicting results on the efficacy of tocilizumab (TCZ) for patients with COVID-19, with many confounders of clinical status and limited duration of the observation. Here, we evaluate the real-world long-term efficacy of TCZ in COVID-19 patients. METHODS: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigo, Masayuki, Rasmy, Laila, May, Sarah B., Rao, Aishwarya, Karimaghaei, Sam, Kannadath, Bijun Sai, De la Hoz, Alejandro, Arias, Cesar A., Li, Liang, Zhi, Degui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479513/
https://www.ncbi.nlm.nih.gov/pubmed/34597766
http://dx.doi.org/10.1016/j.ijid.2021.09.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479513/
https://www.ncbi.nlm.nih.gov/pubmed/34597766
http://dx.doi.org/10.1016/j.ijid.2021.09.067

Ejemplares similares